¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phage integrase family"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latent phage
    ÀáÀçÆÄÁö
  • phage
    ÆÄÁö
  • phage genome
    ÆÄÁöÀ¯Àüü
  • temperate phage
    ¿Â¼øÆÄÁö
  • temperature-sensitive phage
    ¿Âµµ¹Î°¨ÆÄÁö
  • vegetative phage
    Áõ½ÄÇüÆÄÁö
  • virulent phage
    µ¶¼ºÆÄÁö, ¿ë±Õ¼ºÆÄÁö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latent phage
    ÀáÀçÆÄÁö
  • phage map
    ÆÄÁöÀ¯ÀüÀÚÁöµµ
  • phage
    ÆÄÁö
  • phage plaque-forming unit
    ÆÄÁö¿ë±ÕÇü¼º´ÜÀ§, ÆÄÁöÇöóÅ©Çü¼º´ÜÀ§
  • temperate phage
    ÀáÀçÆÄÁö, ¿Â¼øÆÄÁö
  • temperature-sensitive phage
    ¿Âµµ¹Î°¨ÆÄÁö
  • transducing phage
    ÇüÁúµµÀÔÆÄÁö
  • vegetative phage
    Áõ½ÄÇüÆÄÁö
  • virulent phage
    ¿ë±Õ¼ºÆÄÁö, µ¶¼ºÆÄÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phage resistance
    ÆÄÁö³»¼º
  • phage type
    ÆÄÁöÇü(¡­úþ).
  • phage type
    ÆÄÁöÇü
  • phage typing
    ÆÄÁöÇü¹ú(¡­úþܬ).
  • phage typing
    ÆÄÁöÇüº°
  • phage, Mu (¥ì)
    ¹ÂÆÄÁö, ¥ìÆÄÁö
  • phage, T-even
    T¦¼öÆÄÁö
  • phage, T-odd
    TȦ¼öÆÄÁö
  • phage, defective
    °á¼ÕÆÄÁö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hierarchial family tree
    °èÅë°¡°è¼ö
  • immunoglobulin supergene family
    ¸é¿ª±Û·ÎºÒ¸° À¯ÀüÀÚÃʰŴëÁý´Ü
  • infantile amaurotic family idiocy
    ¿µ¾ÆÈæ³»À强 °¡Á·¼º ¹éÄ¡.
  • infantile amaurotic family idiocy
    ¿µ¾ÆÈæ³»À强 °¡Á·¼º ¹éÄ¡.
  • multidrug resistance gene family
  • skewed family
    ÆíÁß°¡Á·
  • conversion, phage
    ÆÄÁöÀüȯ
  • defective phage
    °á¼ÕÆÄÁö
  • donor-specific phage
    °ø¿©±ÕƯÀÌÆÄÁö
  • helper phage
    Á¶·ÂÆÄÁö
  • inducible phage
    À¯¹ß°¡´ÉÆÄÁö
  • lambda (¥ë) phage
    ¶÷´ÙÆÄÁö, ¥ëÆÄÁö
  • latent phage
    ÀẹÆÄÁö
  • lysogenic phage
    ¿ë¿ø¼ºÆÄÁö
  • mu (¥ì) phage
    ¹ÂÆÄÁö, ¥ìÆÄÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phage lambda
    ¶÷´Ù ÆäÀÌÁö
  • phage lysate
    ÆäÀÌÁö ¿ëÇØ¹°(éÁú°Úª)
  • phage lysozyme
    ÆäÀÌÁö ¶óÀ̼ÒÀÚÀÓ
  • phage M13
    M13 ÆäÀÌÁö
  • phage MS-2
    MS-2 ÆäÀÌÁö
  • phage Qb
    Qb ÆäÀÌÁö
  • phage T
    T ÆäÀÌÁö
  • phage ¥õX174
    ¥õX174 ÆäÀÌÁö
  • RNA phage
    RNA ÆÄÁö
  • temperate phage
    ¿ë¿ø(éÁê«)ÆäÀÌÁö
  • T-even phage
    T- ¦¼ö ÆäÀÌÁö
  • T-odd phage
    T Ȧ¼ö ÆäÀÌÁö
  • T phage
    T ÆäÀÌÁö
  • transducing phage
    ÇüÁúµµÀÔ(û¡òõÓôìý) ÆäÀÌÁö
  • vegetative phage
    Áõ½ÄÇü(ñòãÖúþ) ÆäÀÌÁö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GnRH Gonadotropin Releasing Hormone  [HP 1898, 2034]
  = LHRH
  = Go...
AAMFT American Association for Marriage and Family Therapy
AFTA American Family Therapy Association
CFH complement factor H; Council on Family Health
CFPC College of Family Physicians of Canada
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IN integrase protein
AAFP American Academy of Family Physicians
CFI Camberwell Family Interview
CFS Cancer Family Syndrome
CCFNI Critical Care Family Needs Inventory
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
q beta phage <molecular biology> A single-stranded RNA phage that specifically infects enterobacteria containing the f plasmid. It is widely used to study RNA phage and bacterial cell function.
(10 Oct 1997)
tailed phage A member of a group of hundreds of DNA-based bacteria-infecting viruses which are characterised by a helix-shaped tail and a cube-shaped head.This group includes the viral families Myoviridae, Podoviridae, andSiphoviridae.
(09 Oct 1997)
temperate phage A bacteriophage that integrates its DNA into that of the host (lysogeny) as opposed to virulent phages that lyse the host.
(18 Nov 1997)
T even phage <microbiology> A group of dsDNA bacteriophages of enterobacteria including T2, T4, T6 as opposed to T odd phage (T1, 3, 5 and 7)
(18 Nov 1997)
lambda phage <virology> Bacterial DNA virus, first isolated from E. Coli. Its structure is similar to that of the T even phages.
Lambda genetic material consists of a double-stranded DNA molecule with 5' twelve-base-pair sticky ends, known as cos sites, which permit circularisation of the DNA molecule. It shows a lytic cycle and a lysogenic cycle and studies on the control of these alternative cycles have been very important for our understanding of the regulation of gene transcription.
It is used as a cloning vector, accommodating fragments of DNA up to 15 kilobase pairs long. For larger pieces, the cosmid vector was constructed from its ends.
(14 Mar 2000)
lytic phage A bacteriophage (virus which infects bacteria) that can only follow the lytic pathway to completing its lytic cycle, and does not have the mechanisms to enter the lysogenic pathway.
(09 Oct 1997)
alu-equivalent family A set of sequences in a mammalian genome that is related to the human Alu family.
(05 Mar 2000)
alu family A set of dispersed sequences in the human genome having Alu cleavage sites at each end.
(05 Mar 2000)
cancer family A group of blood relatives of whom several have had cancer; the mode of aggregation may be genetic and homogeneous, as in familial polyposis of the colon; diverse as in neurofibromatosis; or due to common exposure to a carcinogenic or oncogenic agent, such as a virus.
(05 Mar 2000)
gene family <molecular biology> A set of genes coding for diverse proteins which, by virtue of their high degree of sequence similarity, are believed to have evolved from a single ancestral gene. An example is the immunoglobulin family where the characteristic features of the constant domains are found in various cell surface receptors.
(18 Nov 1997)
physicians, family Those physicians who have completed the education requirements specified by the american academy of family physicians.
(12 Dec 1998)
colon cancer, family history of Colorectal cancer can run in families. The colon cancer risk is higher if an immediate (first-degree) family member (parents, siblings or children) had colorectal cancer and even higher if more than one such relative had colorectal cancer or if a family member developed the cancer at young age (younger than 55 years). Under any of these circumstances, individuals are recommended to undergo a colonoscopy every three years starting at an age that is 7-10 years younger than when the youngest family member with the cancer wasdiagnosed. For example, if a parent had colon cancer diagnosed at age 50, colonoscopy should start in that person's children at 40-43 years of age.
(12 Dec 1998)
multigene family <molecular biology> A set of genes coding for diverse proteins which, by virtue of their high degree of sequence similarity, are believed to have evolved from a single ancestral gene. An example is the immunoglobulin family where the characteristic features of the constant domains are found in various cell surface receptors.
(18 Nov 1997)
professional-family relations The interactions between the professional person and the family.
(12 Dec 1998)
src-family kinases <enzyme> Family of non-receptor protein-tyrosine kinases homologous to src. They are closely related intracellular enzymes that participate in signal transduction pathways in a variety of haemopoietic cells and especially their surface receptors.
Registry number: EC 2.7.1.-
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • family hotel
    °¡Á· ÇÒÀΠȣÅÚ
  • family hour
    °¡Á· ½Åû ½Ã°£
  • family jewels
    °íȯ
  • family life cycle
    °¡Á· ÁÖ±â
  • family likeness
    °¡Á·³¢¸®ÀÇ ´àÀº Á¡
  • family man
    °¡Á¤À» °¡Áø³²ÀÚ
  • family medicine
    °¡Á· ÀÇ·á
  • family name
    ¼º
  • family planning
    °¡Á·°èȹ
  • family practice
    =family medicine
  • family practitioner
    =family doctor
  • family room
    °¡Á¤ ¿À¶ô½Ç;°Å½Ç
  • family skeleton
    Áý¾È³»ÀÇ ºñ¹Ð
  • family style
    °¢ÀÚ°¡ ¶°¸Ô°Ô Å«±×¸©¿¡ ´ãÀ½
  • family therapist
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á